Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2001-8-6
pubmed:abstractText
Coronary responses to adenosine agonists were assessed in perfused mouse and rat hearts. The roles of nitric oxide (NO) and ATP-dependent K(+) channels (K(ATP)) were studied in the mouse. Resting coronary resistance was lower in mouse vs rat, as was minimal resistance (2.2+/-0.1 vs 3.8+/-0.2 mmHg ml(-1) min(-1) g(-1)). Peak hyperaemic flow after 20 - 60 s occlusion was greater in mouse. Adenosine agonists induced coronary dilation in mouse, with pEC(50)s of 9.4+/-0.1 for 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethyl carboxamidoadenosine (CGS21680, A(2A)-selective agonist), 9.3+/-0.1 for 5'-N-ethylcarboxamidoadenosine (NECA, A(1)/A(2) agonist), 8.4+/-0.1 for 2-chloroadenosine (A(1)/A(2) agonist), 7.7+/-0.1 for N(6)-(R)-(phenylisopropyl)adenosine (R-PIA, A(1)/A(2B) selective), and 6.8+/-0.2 for adenosine. The potency order (CGS21680=NECA>2-chloroadenosine>R-PIA>adenosine) supports A(2A) adenosine receptor-mediated dilation in mouse coronary vessels. 0.2 - 2 microM of the A(2B)-selective antagonist alloxazine failed to alter CGS21680 or 2-chloroadenosine responses. pEC(50)s in rat were 6.7+/-0.2 for CGS21680, 7.3+/-0.1 for NECA, 7.6+/-0.1 for 2-chloroadenosine, 7.2+/-0.1 for R-PIA, and 6.2+/-0.1 for adenosine (2-chloroadenosine>NECA=R-PIA>CGS21680> adenosine), supporting an A(2B) adenosine receptor response. NO-synthase antagonism with 50 microM N(G)-nitro L-arginine (L-NOARG) increased resistance by approximately 25%, and inhibited responses to CGS21680 (pEC(50)=9.0+/-0.1), 2-chloroadenosine (pEC(50)=7.3+/-0.2) and endothelial-dependent ADP, but not sodium nitroprusside (SNP). K(ATP) channel blockade with 5 microM glibenclamide increased resistance by approximately 80% and inhibited responses to CGS21680 in control (pEC(50)=8.3+/-0.1) and L-NOARG-treated hearts (pEC(50)=7.3+/-0.1), and to 2-chloroadenosine in control (pEC(50)=6.7+/-0.1) and L-NOARG-treated hearts (pEC(50)=5.9+/-0.2). In summary, mouse coronary vessels are more sensitive to adenosine than rat vessels. A(2A) adenosine receptors mediate dilation in mouse coronary vessels vs A(2B) receptors in rat. Responses in the mouse involve a sensitive NO-dependent response and K(ATP)-dependent dilation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-10372822, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-10386235, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-10525085, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-10644597, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-11158988, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-11162132, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-11275007, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-2167736, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-2194223, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-2333104, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-2464158, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-2580134, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-2937926, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-526709, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-6254686, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-7163654, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-8135856, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-8293769, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-8358543, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-8358566, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-8548172, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-8680745, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-8832079, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-8840867, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-9262401, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-9378250, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-9421303, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-9495868, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-9888251, http://linkedlifedata.com/resource/pubmed/commentcorrection/11487517-9920286
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-(4-(2-carboxyethyl)phenethylamino)..., http://linkedlifedata.com/resource/pubmed/chemical/2-Chloroadenosine, http://linkedlifedata.com/resource/pubmed/chemical/Adenosine, http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Adenosine-5'-(N-ethylcarboxamide), http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glyburide, http://linkedlifedata.com/resource/pubmed/chemical/N-(1-methyl-2-phenylethyl)adenosine, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Nitroarginine, http://linkedlifedata.com/resource/pubmed/chemical/Phenethylamines, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Purinergic P1 Receptor Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P1, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
133
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1063-72
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:11487517-2-Chloroadenosine, pubmed-meshheading:11487517-Adenosine, pubmed-meshheading:11487517-Adenosine Triphosphate, pubmed-meshheading:11487517-Adenosine-5'-(N-ethylcarboxamide), pubmed-meshheading:11487517-Animals, pubmed-meshheading:11487517-Coronary Vessels, pubmed-meshheading:11487517-Dose-Response Relationship, Drug, pubmed-meshheading:11487517-Enzyme Inhibitors, pubmed-meshheading:11487517-Glyburide, pubmed-meshheading:11487517-Heart, pubmed-meshheading:11487517-Male, pubmed-meshheading:11487517-Mice, pubmed-meshheading:11487517-Mice, Inbred C57BL, pubmed-meshheading:11487517-Nitric Oxide Synthase, pubmed-meshheading:11487517-Nitroarginine, pubmed-meshheading:11487517-Phenethylamines, pubmed-meshheading:11487517-Potassium Channel Blockers, pubmed-meshheading:11487517-Purinergic P1 Receptor Agonists, pubmed-meshheading:11487517-Rats, pubmed-meshheading:11487517-Rats, Wistar, pubmed-meshheading:11487517-Receptors, Purinergic P1, pubmed-meshheading:11487517-Vascular Resistance, pubmed-meshheading:11487517-Vasodilation, pubmed-meshheading:11487517-Vasodilator Agents
pubmed:year
2001
pubmed:articleTitle
Functional characterization of coronary vascular adenosine receptors in the mouse.
pubmed:affiliation
National Heart Foundation Research Centre, School of Health Science, Griffith University, Southport, QLD 4217, Australia.
pubmed:publicationType
Journal Article, Comparative Study, In Vitro
More...